CA2082811A1 - Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique - Google Patents

Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique

Info

Publication number
CA2082811A1
CA2082811A1 CA002082811A CA2082811A CA2082811A1 CA 2082811 A1 CA2082811 A1 CA 2082811A1 CA 002082811 A CA002082811 A CA 002082811A CA 2082811 A CA2082811 A CA 2082811A CA 2082811 A1 CA2082811 A1 CA 2082811A1
Authority
CA
Canada
Prior art keywords
tetrahydrofolate
methylene
modulator
chemotherapeutic agent
ch2fh4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002082811A
Other languages
English (en)
Other versions
CA2082811C (fr
Inventor
Colin P. Spears
Bengt G. Gustavsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2082811A1 publication Critical patent/CA2082811A1/fr
Application granted granted Critical
Publication of CA2082811C publication Critical patent/CA2082811C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002082811A 1990-05-11 1991-05-13 Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique Expired - Lifetime CA2082811C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52171290A 1990-05-11 1990-05-11
US521,712 1990-05-11
PCT/US1991/003186 WO1991017660A1 (fr) 1990-05-11 1991-05-13 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique

Publications (2)

Publication Number Publication Date
CA2082811A1 true CA2082811A1 (fr) 1991-11-12
CA2082811C CA2082811C (fr) 2004-11-16

Family

ID=24077829

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002082811A Expired - Lifetime CA2082811C (fr) 1990-05-11 1991-05-13 Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique

Country Status (3)

Country Link
AU (1) AU7953291A (fr)
CA (1) CA2082811C (fr)
WO (1) WO1991017660A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684644A5 (de) 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
SE0303526D0 (sv) * 2003-12-22 2003-12-22 Biofol Ab Chemotherapeutic agents
EP2617421A1 (fr) * 2012-01-20 2013-07-24 Isofol Medical AB Tétrahydrofolates en combinaison avec les inhibiteurs EGFR dans l'utilisation pour le traitement du cancer

Also Published As

Publication number Publication date
WO1991017660A1 (fr) 1991-11-28
CA2082811C (fr) 2004-11-16
AU7953291A (en) 1991-12-10

Similar Documents

Publication Publication Date Title
CA2111527A1 (fr) Phosphonooxymethylethers de derives du taxane
CA2129288A1 (fr) Esters phosphonooxymethyliques de derives de taxane
CA2016659A1 (fr) Compose stabilise contenant un facteur de croissance epidermique
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
CA2163706A1 (fr) Derives amino-acides de paclitaxel
CA2182582A1 (fr) Compositions contenant du nebivolol micronise
CA2125895A1 (fr) Coordinats renfermant des heteroatomes; complexes metalliques de ces coordinats
CA2182200A1 (fr) Formulations s'appliquant au facteur ix
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
CA2091360A1 (fr) Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques
CA2124677A1 (fr) Agents immunopotentialisateurs et leurs sels physiologiquement compatibles
CA2110693A1 (fr) Derive d'acide amine anticonvulsif
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
GEP20002331B (en) Alkylated Raphamicine Derivatives
CA2150251A1 (fr) Lyospheres contenant de la gonadotropine
CA2163361A1 (fr) Derives de substitution de guanidines, agents therapeutiques
MY101784A (en) Novel pharmacological compounds
CA2163837A1 (fr) Hydrates de paclitaxel cristallises
CA2114136A1 (fr) Complexes de gallium (iii), procede de production et compositions pharmaceutiques en contenant
CA2152771A1 (fr) Derives 7-o-ether de taxane
CA2217710A1 (fr) Substance anticancereuse inhibant les metastases cancereuses
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
CA2082811A1 (fr) Utilisation du 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique
CA2114859A1 (fr) Compose cytotoxique et antiviral
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry